International Stem Cell Corporation
ISCO
$0.40
$0.039.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.51M | 9.29M | 9.10M | 9.39M | 9.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.51M | 9.29M | 9.10M | 9.39M | 9.20M |
| Cost of Revenue | 4.29M | 4.00M | 4.03M | 3.96M | 3.88M |
| Gross Profit | 5.23M | 5.29M | 5.07M | 5.43M | 5.32M |
| SG&A Expenses | 5.51M | 5.47M | 5.24M | 5.06M | 5.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.85M | 9.53M | 9.37M | 9.29M | 9.29M |
| Operating Income | -333.00K | -242.00K | -267.00K | 97.00K | -87.00K |
| Income Before Tax | -582.00K | -382.00K | -418.00K | -59.00K | -241.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.58 | -0.38 | -0.42 | -0.06 | -0.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -582.00K | -382.00K | -418.00K | -59.00K | -241.00K |
| EBIT | -333.00K | -242.00K | -267.00K | 97.00K | -87.00K |
| EBITDA | -162.00K | -44.00K | -48.00K | 316.00K | 129.00K |
| EPS Basic | -0.08 | -0.06 | -0.06 | -0.02 | -0.04 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.03 | 0.00 | -0.02 |
| EPS Diluted | -0.08 | -0.06 | -0.06 | -0.02 | -0.04 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.03 | 0.00 | -0.02 |
| Average Basic Shares Outstanding | 32.02M | 32.02M | 32.02M | 32.02M | 32.02M |
| Average Diluted Shares Outstanding | 32.18M | 32.18M | 32.18M | 32.18M | 32.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |